Business · 29/04/2010
FDA Releases Draft Guidance on User Fees for 513(g) Requests for Information
The Food and Drug Administration (FDA) has made available a draft guidance document outlining the user fees associated with 513(g) requests for information, which will be reviewed by industry and FDA staff.
Original source language: Federal Register — Health and Human ServicesOpen original release →